Carborane-containing compounds have also been explored as selective inhibitors for carbonic anhydrases such as the tumor-associated isoform CAIX over the non-tumor-associated isoform CAII [175], with one compound showing approximately 1230-fold more selectivity for CAIX over CAII [176]. The gene discussed is CA2; the disease is neoplasm.